Načítá se...
Monoclonal Anti-TNF-α Antibodies for Severe Steroid-Dependent Asthma: A Case Series
BACKGROUND: Refractory asthma represents an important condition, with considerable morbidity and mortality. Tumor necrosis factor α (TNF-α) is a potential target for treatment of severe asthma. However, controlled studies have shown controversial results and the risk-benefit profile of TNF-blocking...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bentham Open
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3601337/ https://ncbi.nlm.nih.gov/pubmed/23526476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874306401307010021 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|